New drug policy corners local drug makers

Published: 2007-10-22 06:57:00

Updated: 2007-10-22 06:57:00

The current positive list system, under which only medicines with proven efficacy and price-competitiveness will be covered by health insurance, is dealing a blow to the domestic pharmaceutical industry, a lawmaker said during a parliamentary audit of the Ministry of Health and Welfare on October...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK